ArticleAdvanced biomedical research2025
Modeling Normal Tissue Complication Probability of Radiation-Induced Alopecia Following Intensity-Modulated Radiation Therapy in Glioblastoma Patients.
Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glioblastoma multiforme (GBM) is an aggressive primary brain tumor requiring radiotherapy (RT), which often leads to radiation-induced alopecia (RIA), a distressing toxicity impacting quality of life. This study establishes the first normal tissue complication probability (NTCP) framework for RIA in GBM patients, comparing the Lyman-Kutcher-Burman (LKB) model and multivariate logistic regression. Materials and Methods: A prospective cohort of 41 GBM patients undergoing intensity-modulated RT (IMRT) was analyzed. Scalp contours were generated for dosimetric evaluation, and NTCP was modeled using the LKB framework (parameters: TD Results: Grade 2 RIA incidence was 46.3% at 3 months and 31.7% at 6 months. Dosimetric parameters D Conclusion: Multivariate logistic regression, integrating dosimetric and clinical factors, offers enhanced predictive accuracy for RIA compared to the LKB model. These findings emphasize the importance of optimizing IMRT plans to limit scalp dose and considering chemotherapy in risk stratification. Implementation of these models may improve patient-centered care by balancing tumor control and toxicity reduction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.